Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Days Sales Outstanding : 59.94 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang East-Asia Pharmaceutical Co Days Sales Outstanding?

Zhejiang East-Asia Pharmaceutical Co's average Accounts Receivable for the three months ended in Jun. 2024 was ¥194 Mil. Zhejiang East-Asia Pharmaceutical Co's Revenue for the three months ended in Jun. 2024 was ¥296 Mil. Hence, Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding for the three months ended in Jun. 2024 was 59.94.

The historical rank and industry rank for Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:605177' s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.34 Med: 40.92 Max: 54.9
Current: 48.36

During the past 8 years, Zhejiang East-Asia Pharmaceutical Co's highest Days Sales Outstanding was 54.90. The lowest was 27.34. And the median was 40.92.

SHSE:605177's Days Sales Outstanding is ranked better than
70.29% of 875 companies
in the Biotechnology industry
Industry Median: 72.5 vs SHSE:605177: 48.36

Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding increased from Jun. 2023 (53.24) to Jun. 2024 (59.94).

Zhejiang East-Asia Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang East-Asia Pharmaceutical Co Days Sales Outstanding Chart

Zhejiang East-Asia Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

30.35

36.72

45.11

27.34

32.19

Zhejiang East-Asia Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															53.24	48.64	41.88	46.21	59.94

Competitive Comparison of Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding

For the Biotechnology subindustry, Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding falls into.

Zhejiang East-Asia Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (98.453	+	140.783)	/	2 )	/	1356.448	*	365
=	119.618					/	1356.448	*	365
=	32.19

Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (216.299	+	172.131)	/	2 )	/	295.644	*	365 / 4
=	194.215					/	295.644	*	365 / 4
=	59.94

Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Zhejiang East-Asia Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zhejiang East-Asia Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang East-Asia Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang East-Asia Pharmaceutical Co Ltd (SHSE:605177) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Laodong North Road, 23rd Floor, General Chamber of Commerce Building, Huangyan District, Zhejiang Province, Taizhou, CHN

Website

http://www.eapharm.cn

Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.

Zhejiang East-Asia Pharmaceutical Co Headlines

No Headlines